Valganciclovir-d5 TFA structure
|
Common Name | Valganciclovir-d5 TFA | ||
---|---|---|---|---|
CAS Number | 1402924-31-5 | Molecular Weight | 473.42 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C16H18D5F3N6O7 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Valganciclovir-d5 TFAValganciclovir-d5 (TFA) is the deuterium labeled Valganciclovir TFA[1]. Valganciclovir, the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir. Valganciclovir is an antiviral medication used to treat cytomegalovirus infections[2][3][4]. |
Name | Valganciclovir-d5 TFA |
---|
Description | Valganciclovir-d5 (TFA) is the deuterium labeled Valganciclovir TFA[1]. Valganciclovir, the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir. Valganciclovir is an antiviral medication used to treat cytomegalovirus infections[2][3][4]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C16H18D5F3N6O7 |
---|---|
Molecular Weight | 473.42 |